CLINICAL TRIALS PROFILE FOR BOTOX COSMETIC
✉ Email this page to a colleague
All Clinical Trials for BOTOX COSMETIC
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00002696 ↗ | Combination Chemotherapy in Treating Women With Stage III Breast Cancer | Suspended | Grupo Oncologico Cooperativo del Sur | Phase 3 | 1995-10-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Randomized phase III trial to compare cyclophosphamide, doxorubicin, and fluorouracil with cyclophosphamide, methotrexate, and fluorouracil in treating women with stage III breast cancer. |
| NCT00003893 ↗ | Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast Cancer | Completed | University Hospital Birmingham | Phase 3 | 1998-07-01 | RATIONALE: Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumors cells. Combining chemotherapy with radiation therapy may kill more tumor cells. It is not yet known which regimen of chemotherapy plus radiation therapy is more effective for early-stage breast cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of two different regimens of adjuvant chemotherapy plus radiation therapy in treating women who have early-stage breast cancer. |
| NCT00006256 ↗ | Paclitaxel Plus Radiation Therapy in Treating Women With Stage II or Stage III Breast Cancer | Active, not recruiting | National Cancer Institute (NCI) | Phase 2 | 2000-06-08 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining paclitaxel with radiation therapy may kill more tumor cells. PURPOSE: This trial is to study the effectiveness of concurrent administration of chemotherapy and radiation therapy in treating women who have stage II or stage III breast cancer by examining the complications and cosmetic effects. |
| NCT00006256 ↗ | Paclitaxel Plus Radiation Therapy in Treating Women With Stage II or Stage III Breast Cancer | Active, not recruiting | Case Comprehensive Cancer Center | Phase 2 | 2000-06-08 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining paclitaxel with radiation therapy may kill more tumor cells. PURPOSE: This trial is to study the effectiveness of concurrent administration of chemotherapy and radiation therapy in treating women who have stage II or stage III breast cancer by examining the complications and cosmetic effects. |
| NCT00108121 ↗ | Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Nodular Basal Cell Carcinoma | Completed | Peplin | Phase 2 | 2005-03-01 | The purpose of this study is to determine whether topical application of PEP005 is safe for the treatment of nodular basal cell carcinoma. |
| NCT00108134 ↗ | Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Superficial Basal Cell Carcinoma | Completed | Peplin | Phase 2 | 2005-03-01 | The purpose of this study is to determine whether topical application of PEP005 is safe for the treatment of superficial basal cell carcinoma. |
| NCT00128323 ↗ | A Comparison of Gentian Violet (GV) Mouth Washes, Nystatin, and Ketoconazole Tabs in Treating Oropharyngeal Candidiasis | Completed | British Society for Antimicrobial Chemotherapy | Phase 3 | 2002-11-01 | In resource constrained societies and where HIV is a problem, oral thrush causes significant morbidity. In adults, ketoconazole is used and sometimes oral nystatin. Both drugs are relatively expensive compared to GV solution and ketoconazole has significant side effects especially in association with some of the treatments for HIV related problems. In children, either GV solutions or nystatin are used, GV is a fraction of the cost of nystatin. GV at 1% solution discolours the mouth (blue) and in the older child and adult would mark them out as having HIV infections. A much more dilute solution of GV has proved equally effective in vitro and would not carry the same cosmetic problem. In this study of children, the investigators have compared the 3 solutions, 1% GV, 0.00165% GV and nystatin oral drops - all masked so that they look the same - to see if GV is more effective than nystatin, and to see if the weaker solution of GV is as effective as the stronger solution. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for BOTOX COSMETIC
Condition Name
Clinical Trial Locations for BOTOX COSMETIC
Trials by Country
Clinical Trial Progress for BOTOX COSMETIC
Clinical Trial Phase
Clinical Trial Sponsors for BOTOX COSMETIC
Sponsor Name
